Header Logo

Connection

William Hildebrand to Treatment Outcome

Back to Details
This is a "connection" page, showing publications William Hildebrand has written about Treatment Outcome.
William Hildebrand
Connection Strength
0.009
Treatment Outcome
  1. Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy. J Urol. 2003 Jun; 169(6):2084-8.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.